(Q37659363)

21 August 2017

1 reference

title

Carnitine, valproate, and toxicity (English)

1 reference

21 August 2017

D L Coulter

1

1 reference

21 August 2017

1 January 1991

1 reference

Journal of Child Neurology

21 August 2017

1 reference

21 August 2017

6

1 reference

21 August 2017

7-14

1 reference

21 August 2017

1

1 reference

Carnitine Deficiency of Human Skeletal Muscle with Associated Lipid Storage Myopathy: A New Syndrome

21 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Carnitine: an overview of its role in preventive medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Carnitine deficiency syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Carnitine--metabolism and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Carnitine deficiency, organic acidemias, and Reye's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Valproic acid associated abnormalities of carnitine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Serum carnitine during valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Valproic acid hepatic fatalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Hepatotoxicity in rat following administration of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Effect of valproic acid on hepatic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Valproic acid therapy in childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Acute Hepatic Failure Associated with the Use of Sodium Valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Reye-like syndrome associated with valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Decreased serum carnitine in valproate induced Reye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Asterixis associated with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

The renal origin of sodium valproate-induced hyperammonemia in fasting humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Hepatic and renal contributions to valproic acid-induced hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389100600102

10.1177/088307389100600102

21 January 2018

Identifiers

DOI

0 references

PubMed ID

2002205

1 reference

PubMed ID

2002205